Literature DB >> 28646378

Glucagon stimulation test: has its time come?

Cesar L Boguszewski1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28646378     DOI： 10.1007/s12020-017-1356-8

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  19 in total

Review 1.  Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1).

Authors:  Hemamalini Ketha; Ravinder J Singh
Journal:  Methods       Date:  2015-04-30       Impact factor: 3.608

Review 2.  Hypopituitarism: growth hormone and corticotropin deficiency.

Authors:  Cristina Capatina; John A H Wass
Journal:  Endocrinol Metab Clin North Am       Date:  2014-11-06       Impact factor: 4.741

3.  Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline.

Authors:  Maria Fleseriu; Ibrahim A Hashim; Niki Karavitaki; Shlomo Melmed; M Hassan Murad; Roberto Salvatori; Mary H Samuels
Journal:  J Clin Endocrinol Metab       Date:  2016-10-13       Impact factor: 5.958

Review 4.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: UPDATE ON GROWTH HORMONE STIMULATION TESTING AND PROPOSED REVISED CUT-POINT FOR THE GLUCAGON STIMULATION TEST IN THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY.

Authors:  Kevin C J Yuen; Nicholas A Tritos; Susan L Samson; Andrew R Hoffman; Laurence Katznelson
Journal:  Endocr Pract       Date:  2016-07-13       Impact factor: 3.443

5.  Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery.

Authors:  Christian Berg; Timo Meinel; Harald Lahner; Ali Yuece; Klaus Mann; Stephan Petersenn
Journal:  Eur J Endocrinol       Date:  2009-12-08       Impact factor: 6.664

6.  Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?

Authors:  Halit Diri; Zuleyha Karaca; Yasin Simsek; Fatih Tanriverdi; Kursad Unluhizarci; Ahmet Selcuklu; Fahrettin Kelestimur
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

7.  Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans.

Authors:  E Arvat; B Maccagno; J Ramunni; R Giordano; F Broglio; L Gianotti; M Maccario; F Camanni; E Ghigo
Journal:  Eur J Endocrinol       Date:  2000-11       Impact factor: 6.664

8.  Growth hormone and cortisol secretion in the elderly evaluated using the glucagon stimulation test.

Authors:  Ana Beatriz Winter Tavares; Ignácio Antônio Seixas-da-Silva; Diego H S Silvestre; Maria Fernanda Castelar Pinheiro; Mario Vaisman; Flávia Lucia Conceição
Journal:  Endocrine       Date:  2017-03-11       Impact factor: 3.633

Review 9.  Hypopituitarism.

Authors:  Claire E Higham; Gudmundur Johannsson; Stephen M Shalet
Journal:  Lancet       Date:  2016-03-31       Impact factor: 79.321

Review 10.  How should we interrogate the hypothalamic-pituitary-adrenal axis in patients with suspected hypopituitarism?

Authors:  Aoife Garrahy; Amar Agha
Journal:  BMC Endocr Disord       Date:  2016-06-17       Impact factor: 2.763
View more
  1 in total

Review 1.  Update on GH therapy in adults.

Authors:  Cesar Luiz Boguszewski
Journal:  F1000Res       Date:  2017-11-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.